Market open
Nautilus Biotechnolgy/$NAUT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nautilus Biotechnolgy
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Ticker
$NAUT
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
134
ISIN
US63909J1088
Website
NAUT Metrics
BasicAdvanced
$91M
-
-$0.55
1.21
-
Price and volume
Market cap
$91M
Beta
1.21
52-week high
$2.97
52-week low
$0.66
Average daily volume
177K
Financial strength
Current ratio
17.362
Quick ratio
17.019
Long term debt to equity
12.909
Total debt to equity
15.09
Management effectiveness
Return on assets (TTM)
-19.06%
Return on equity (TTM)
-30.93%
Valuation
Price to book
0.47
Price to tangible book (TTM)
0.47
Price to free cash flow (TTM)
-1.533
Growth
Earnings per share change (TTM)
1.31%
3-year earnings per share growth (CAGR)
0.55%
What the Analysts think about NAUT
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Nautilus Biotechnolgy stock.
NAUT Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
NAUT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
NAUT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Nautilus Biotechnolgy stock?
Nautilus Biotechnolgy (NAUT) has a market cap of $91M as of May 13, 2025.
What is the P/E ratio for Nautilus Biotechnolgy stock?
The price to earnings (P/E) ratio for Nautilus Biotechnolgy (NAUT) stock is 0 as of May 13, 2025.
Does Nautilus Biotechnolgy stock pay dividends?
No, Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders as of May 13, 2025.
When is the next Nautilus Biotechnolgy dividend payment date?
Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders.
What is the beta indicator for Nautilus Biotechnolgy?
Nautilus Biotechnolgy (NAUT) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.